Helsinki University Central Hospital
🇫🇮Finland
- Country
- 🇫🇮Finland
- Ownership
- Private
- Established
- 1958-03-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.hus.fi
Helsinki Ultra-acute Stroke Biomarker Study
Completed
- Conditions
- Acute Stroke
- First Posted Date
- 2014-05-23
- Last Posted Date
- 2016-04-01
- Lead Sponsor
- Helsinki University Central Hospital
- Target Recruit Count
- 1046
- Registration Number
- NCT02145663
- Locations
- 🇫🇮
Helsinki University Central Hospital, Helsinki, Uusimaa, Finland
Incidence of Fluoroquinolone Resistant Bacteria in Patients Undergoing Prostate Biopsy
Completed
- Conditions
- Fluoroquinolone Resistant Enteric Bacteria
- First Posted Date
- 2014-05-16
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Helsinki University Central Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT02140502
- Locations
- 🇫🇮
Department of Urology, Meilahti Hospital, Helsinki, Uusimaa, Finland
🇫🇮Department of Urology, Peijas Hospital, Vantaa, Uusimaa, Finland
Cross-reactive Immunity Elicited by Oral and Parenteral Typhoid Vaccines
Phase 4
- Conditions
- Healthy
- Interventions
- Biological: VivotifBiological: Typherix
- First Posted Date
- 2014-04-23
- Last Posted Date
- 2014-04-23
- Lead Sponsor
- Helsinki University Central Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT02121145
- Locations
- 🇫🇮
Helsinki University Central Hospital, Helsinki, Finland
🇫🇮Aava Medical Centre, Helsinki, Finland
🇫🇮University of Helsinki, Haartman Institute, Helsinki, Finland
Lactobacillus Rhamnosus GG in the Middle Ear and Adenoid Tonsil
Not Applicable
Completed
- Conditions
- Acute Otitis MediaUpper Respiratory Infection
- Interventions
- Dietary Supplement: Lactobacillus rhamnosus GG
- First Posted Date
- 2014-04-10
- Last Posted Date
- 2021-06-02
- Lead Sponsor
- Helsinki University Central Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT02110732
Efficacy Study of Articaine Lozenge to Enhance the Procedural Compliance of the Adults Undergoing Gastroduodenoscopy
Phase 4
- Conditions
- HematemesisHeartburnDyspepsiaAbdominal Pain
- Interventions
- Drug: Anesthetics, Local
- First Posted Date
- 2014-04-07
- Last Posted Date
- 2019-05-06
- Lead Sponsor
- Helsinki University Central Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT02105090
- Locations
- 🇫🇮
Department of Anesthesiology and Intensive care medicine, Divison of Surgery, Meilahti hospital, Helsinki University Central Hospital, Helsinki, Uusimaa, Finland
Long-term Effects of Lifestyle Intervention During Pregnancy in High Risk Women and in Their Offspring - Role of Environmental, Genetic and Epigenetic Factors
Completed
- Conditions
- Type 2 DiabetesObesityMetabolic Syndrome
- First Posted Date
- 2014-01-29
- Last Posted Date
- 2019-04-16
- Lead Sponsor
- Helsinki University Central Hospital
- Target Recruit Count
- 680
- Registration Number
- NCT02048839
- Locations
- 🇫🇮
Helsinki University, Helsinki, Finland
The Effects of Immunotherapy in the Nose
Not Applicable
Completed
- Conditions
- Rhinitis, Allergic, Seasonal
- Interventions
- Drug: birch pollen subcutaneous immunotherapy
- First Posted Date
- 2013-11-15
- Last Posted Date
- 2021-06-10
- Lead Sponsor
- Helsinki University Central Hospital
- Target Recruit Count
- 16
- Registration Number
- NCT01985542
Mechanisms of Ultra-acute Hyperglycemia After Successful Resuscitation From Out-of-hospital Cardiac Arrest
Completed
- Conditions
- Heart ArrestCardiac Arrest
- First Posted Date
- 2013-10-23
- Last Posted Date
- 2018-03-13
- Lead Sponsor
- Helsinki University Central Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT01968148
- Locations
- 🇫🇮
Helsinki Emergency Medical Services, Helsinki, Finland
🇫🇮Helsinki Area Helicopter Emergency Medical Services, Vantaa, Finland
Covered Metal Stent for Benign Biliary Stricture Caused by Chronic Pancreatitis
Not Applicable
- Conditions
- Biliary StrictureChronic Pancreatitis
- Interventions
- Procedure: ERCPDevice: covered self-expanding biliary metal stent, 12mm in diameterDevice: covered self-expanding biliary metal stent, 10mm in diameter
- First Posted Date
- 2013-08-28
- Last Posted Date
- 2022-08-17
- Lead Sponsor
- Helsinki University Central Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT01929538
- Locations
- 🇫🇮
Helsinki University Central Hospital, Helsinki, Finland
PCV13 + Hepatitis a Vaccine for Adults
Phase 4
Completed
- Conditions
- Measurement of Immune Response to Prevenar13Measurement of Immune Response to Hepatitis a
- Interventions
- Biological: Prevenar13
- First Posted Date
- 2013-08-21
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Helsinki University Central Hospital
- Target Recruit Count
- 305
- Registration Number
- NCT01926860
- Locations
- 🇫🇮
Aava Medical Centre, Helsinki, Finland
🇸🇪Department of Infectious Diseases, Eskilstuna, Sweden
© Copyright 2025. All Rights Reserved by MedPath